Oncept IL-2

Veterinary Product Information

Target Species Cats
Active Substances Feline interleukin-2 recombinant canarypox virus
Pharmaceutical Form Lyophilisate for suspension for injection
Therapeutic Group Immunomodulator
Authorisation Route National
Legal Category POM-V
Controlled Drug Status Not a controlled drug
Marketing Authorisation Holder Boehringer Ingelheim Vetmedica Gmbh
Distributors <span>Boehringer Ingelheim Vetmedica GmbH</span>
Territory Great Britain
SPC Oncept IL-2 SPC
UKPAR Not available